Verve Therapeutics, Inc.
VERVDelisted Jul 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840574
Verve Therapeutics, Inc. was delisted on Jul 25, 2025; its insiders filed their last Form 4 on Jul 28, 2025; 176 institutions reported holding it in 13F filings for Q2 2025, worth $819.4M in total; no superinvestor held it.
13F holders, Q4 2025
Institutional positions in Verve Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
VERV is no longer listed, and 13F filings after Q2 2025 list far fewer holders. See Q2 2025
- Institutional holders
- 4
- −5 vs. Q3 2025
- Shares held
- 50.0K
- −205.3K (−80.4%) vs. Q3 2025
- Total value
- $344.0K
- −$1.19M (−77.5%) vs. Q3 2025
- New holders
- 0
- 0 more added
- Sold out
- 5
- 0 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VERV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2 | $0 |
| Q1 2026 | 3 | $0 |
| Q4 2025 | 4 | $344.0K |
| Q3 2025 | 9 | $1.53M |
| Q2 2025 | 176 | $819.4M |
| Q1 2025 | 191 | $369.3M |
| Q4 2024 | 166 | $443.9M |
| Q3 2024 | 174 | $364.6M |
| Q2 2024 | 167 | $371.8M |
| Q1 2024 | 163 | $1.08B |
| Q4 2023 | 157 | $1.04B |
| Q3 2023 | 134 | $847.0M |
| Q2 2023 | 121 | $1.16B |
| Q1 2023 | 125 | $911.8M |
| Q4 2022 | 123 | $1.21B |
| Q3 2022 | 124 | $2.08B |
| Q2 2022 | 101 | $695.8M |
| Q1 2022 | 92 | $1.06B |
| Q4 2021 | 96 | $1.66B |
| Q3 2021 | 73 | $1.81B |
| Q2 2021 | 69 | $2.25B |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Verve Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DekaBank Deutsche Girozentrale | 24,000 | $344.0K | 0.00% | 00.0% | Unchanged |
| Cim Investment Mangement Inc | 25,747 | $0 | 0.00% | 00.0% | Unchanged |
| GAMMA Investing LLC | 257 | $0 | 0.00% | 00.0% | Unchanged |
| Murphy & Mullick Capital Management Corp | 43 | $0 | 0.00% | 00.0% | Unchanged |
| Greenland Capital Management LP | 0 | $0 | 0.00% | −49,506−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −17,417−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −10,026−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −3,344−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −124,964−100.0% | Sold out |